Genomic & Biopharma News

Study finds 200% increase in consumption of low-calorie sweeteners among U.S. children
About 25 percent of children and more than 41 percent of adults in the United States reported consuming foods and beverages containing low-calorie sweeteners such as aspartame, sucralose, and saccharin in a recent nationwide nutritional survey, according to a study out today.
News Medical Life Sciences, 2017-01-10 11:21:36

New model could help internet addicts realize problem and reduce usage
Research has shown that internet addicts do not always feel guilty about their usage, and in many cases, they do not even perceive their usage as problematic.
News Medical Life Sciences, 2017-01-10 11:10:39

Takeda shells out $5.2bn on Ariad
Takeda has announced its intention to buy US drugmaker Ariad for around $5.2 billion, in a move designed to boost its oncology offering.
PharmaTimes, 2017-01-10 11:08:31

Allergan broadens pipeline with Parkinson’s disease deal
Dublin, Ireland-based Allergan has stepped into the field of Parkinson's disease with an option to acquire US-based neurodegenerative research group Lysosomal Therapeutics (LTI).
PharmaTimes, 2017-01-10 11:04:41

Welsh gov launches £80m new treatment fund
A five-year, £80 million new treatment fund has now been launched in Wales in the hope of accelerating patient access to novel therapies.
PharmaTimes, 2017-01-10 11:00:35

Amgen, Immatics link in $1.3bn cancer deal
US biotech giant Amgen and Germany's Immatics Biotechnologies GmbH have announced a deal potentially worth more than $1.3 billion to develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancers.
PharmaTimes, 2017-01-10 10:57:04

NeuroVive pipeline rebuild continues with Karolinska pact
NeuroVive pipeline rebuild continues with Karolinska pact nick.paul.taylor Tue, 01/10/2017 - 05:56
Fierce Biotech, 2017-01-10 10:56:43

Developing high field solid-state NMR for the characterization of complex targets
Solid-state NMR spectroscopy is a technique used by scientists to provide valuable information in the analysis of solid materials. It provides unique and specific insights into the structure, dynamics, and reactivity of all kinds of materials.
News Medical Life Sciences, 2017-01-10 10:04:35

Okayama University researchers uncover potential new therapeutic target for invasive bladder cancer
Researchers at Okayama University have uncovered a potential new therapeutic target for invasive bladder cancer. The GTP hydrolysing enzyme (GTPase), called Dynamin2, facilitates the rapid invasion of cancer into surrounding tissues; inhibiting its activity could limit the progression of bladder cancer.
News Medical Life Sciences, 2017-01-10 09:20:15